| Nov 17, 2025 |
Nov 19, 2025 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-806
|
-2.60%
|
✗
|
$25.9K |
| Aug 15, 2025 |
Aug 19, 2025 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-1,393
|
-5.31%
|
✗
|
$15.1K |
| May 15, 2025 |
May 19, 2025 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
42.5
|
-2,349
|
-3.96%
|
✗
|
$79.4K |
| Feb 25, 2025 |
Feb 27, 2025 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
42.5
|
-3,748
|
-13.87%
|
✗
|
$125K |
| Feb 18, 2025 |
Feb 20, 2025 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-1,261
|
-5.44%
|
✗
|
$42.2K |
| Nov 15, 2024 |
Nov 19, 2024 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-526
|
-2.39%
|
✗
|
$31.3K |
| Aug 15, 2024 |
Aug 19, 2024 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-766
|
-5.32%
|
✗
|
$33.6K |
| May 28, 2024 |
May 28, 2024 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-134
|
-1.13%
|
✗
|
$6.9K |
| May 15, 2024 |
May 17, 2024 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
42.5
|
-1,561
|
-4.42%
|
✗
|
$112.5K |
| Feb 27, 2024 |
Feb 29, 2024 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-130
|
-1.98%
|
✗
|
$3.6K |
| Feb 15, 2024 |
Feb 20, 2024 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-262
|
-2.12%
|
✗
|
$6.4K |
| Nov 27, 2023 |
Nov 29, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-129
|
-2.17%
|
✗
|
$2.5K |
| Nov 15, 2023 |
Nov 17, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
77.5
|
+344
|
2.20%
|
✗
|
$4K |
| Aug 28, 2023 |
Aug 30, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-129
|
-2.74%
|
✗
|
$3.5K |
| Aug 15, 2023 |
Aug 17, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-221
|
-2.57%
|
✗
|
$6.4K |
| May 30, 2023 |
May 30, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-129
|
-3.18%
|
✗
|
$3.4K |
| May 15, 2023 |
May 17, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-713
|
-10.44%
|
✗
|
$22.9K |
| Feb 27, 2023 |
Mar 1, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-153
|
-6.16%
|
✗
|
$5.5K |
| Feb 15, 2023 |
Feb 17, 2023 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-67
|
-3.07%
|
✗
|
$2.9K |
| Nov 28, 2022 |
Nov 30, 2022 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-129
|
-6.01%
|
✗
|
$5.1K |
| Nov 15, 2022 |
Nov 17, 2022 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-57
|
-3.11%
|
✗
|
$2.4K |
| Aug 29, 2022 |
Aug 31, 2022 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-129
|
-7.18%
|
✗
|
$6K |
| Aug 15, 2022 |
Aug 17, 2022 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-57
|
-3.85%
|
✗
|
$3.1K |
| May 27, 2022 |
Jun 1, 2022 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
47.5
|
-129
|
-8.91%
|
✗
|
$9.1K |
| May 16, 2022 |
May 18, 2022 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-225
|
-17.31%
|
✗
|
$16.6K |
| Feb 28, 2022 |
Mar 2, 2022 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-153
|
-19.05%
|
✗
|
$17.2K |
| Dec 27, 2021 |
Dec 29, 2021 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
10.0
|
-1,084
|
-71.55%
|
✓
|
$164.1K |
| Dec 7, 2021 |
Dec 9, 2021 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
10.0
|
-1,083
|
-71.53%
|
✓
|
$151.6K |
| Nov 29, 2021 |
Dec 1, 2021 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-185
|
-30.03%
|
✗
|
$24K |
| Nov 3, 2021 |
Nov 5, 2021 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
5.0
|
-21,785
|
-98.90%
|
✓
|
$3.1M |
| Aug 27, 2021 |
Aug 31, 2021 |
TANDEM DIABETES CARE INC
|
EVP, Chief Strategy Officer |
Sell |
46.3
|
-129
|
-9.58%
|
✗
|
$14.2K |